Estrogen and Progestin Induce the Migration of Pulmonary Artery Smooth Muscle Cells with the Contractile Phenotype Via Different Mechanisms

Wei-ping Hu,Shan-qun Li,Dong Liu
DOI: https://doi.org/10.1183/13993003.congress-2021.pa595
2021-01-01
Abstract:Background: Compared to male, high prevalence of female is observed among nearly all the subtypes of pulmonary artery hypertension (PAH). However, the effects of estrogen were self-contradictory in PAH animal models. Few studies investigated the role of progestin in PAH. Aim: To identify the effects of estradiol and progestin on human pulmonary artery smooth muscle cells (hPASMCs) and explore the mechanisms. Method: Contractile hPASMCs were purchased from ScienCell Research Laboratories®. Passage 3-8 was used for subsequent experiments. Proliferation activity was detected by Alarmar blue assay, and migration activity was examined via wound healing and transwell chamber. Phalloidine was used for staining of F-actin. Next-generation sequencing (NGS) was performed to explore other underlying mechanisms. Result: Estradiol and progestin did not influence the proliferation of contractile hPASMCs but promote its migration activity. Among four migration-associated pathways in vascular SMCs, estradiol promote migration via phosphorylation of Src, which was reversed by src inhibitor Saracatinib. In addition, progestin did not affect the activation of these pathways, but reduced the phosphorylation of cofilin to increase the reorganization of F-actin. The results of NGS demonstrated that estradiol and progestin had obvious effects on migration of contractile hPASMCs by regulating the expression of similar genes, rather than proliferation. Conclusion: In normal contractile PASMCs, estradiol and progestin increased the migration activity by phosphorylation of Src and reorganization of F-actin, respectively.
What problem does this paper attempt to address?